Asparaginase pharmacology: challenges still to be faced Claudia Lanvers-Kaminsky Review Article 14 February 2017 Pages: 439 - 450
Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives Archana Bhaw-LuximonDhanjay Jhurry Review Article 16 February 2017 Pages: 451 - 466
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting Joseph V. Pergolizzi Jr.Robert TaylorRobert B. Raffa Review Article 24 February 2017 Pages: 467 - 477
Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer Jing ZhangJinyu LiuLi Li Original Article 08 February 2017 Pages: 479 - 487
Phase 1 study of new formulation of patritumab (U3-1287) Process 2, a fully human anti-HER3 monoclonal antibody in combination with erlotinib in Japanese patients with advanced non-small cell lung cancer Toshio ShimizuKimio YonesakaKazuhiko Nakagawa Original Article Open access 31 January 2017 Pages: 489 - 495
Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer Hisao ImaiTomohito KuwakoMasanobu Yamada Original Article Open access 06 February 2017 Pages: 497 - 505
Absorption, metabolism, and excretion of [14C]ponatinib after a single oral dose in humans Yihua E. YeCaroline N. WoodwardNarayana I. Narasimhan Original Article Open access 09 February 2017 Pages: 507 - 518
Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial Junichi KoikeKimihiko FunahashiShingo Kameoka Original Article 01 February 2017 Pages: 519 - 525
Effect of food on the bioavailability of palbociclib Ana Ruiz-GarciaAnna PlotkaDiane D. Wang Original Article 15 February 2017 Pages: 527 - 533
Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients Zhan WangJuan ChenWei-Bing Zhou Original Article 27 February 2017 Pages: 535 - 543
An allometric pharmacokinetic/pharmacodynamics model for BI 893923, a novel IGF-1 receptor inhibitor Melanie I. TitzeOtmar SchaafThorsten Lehr Original Article 27 February 2017 Pages: 545 - 558
Effect of alectinib on cardiac electrophysiology: results from intensive electrocardiogram monitoring from the pivotal phase II NP28761 and NP28673 studies Peter N. MorcosKatrijn BogmanBogdana Balas Original Article 27 February 2017 Pages: 559 - 568
NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysis Toshihiko DoiTetsuya HamaguchiAtsushi Ohtsu Original Article Open access 21 February 2017 Pages: 569 - 578
Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab Hidekazu KuramochiMasayuki AndoKazuhiko Hayashi Original Article 17 February 2017 Pages: 579 - 585
Population pharmacokinetics of ABT-767 in BRCA1 or BRCA2 mutation carriers with advanced solid tumors or in subjects with high grade serous ovarian, primary peritoneal or fallopian tube cancer Rajendar K. MittapalliSilpa NuthalapatiHao Xiong Original Article 28 February 2017 Pages: 587 - 594
Positive relationship between subsequent chemotherapy and overall survival in pancreatic cancer: meta-analysis of postprogression survival for first-line chemotherapy Akiyoshi KasugaYasuo HamamotoTakanori Kanai Original Article 25 February 2017 Pages: 595 - 602
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade glioma Jennifer L. ClarkeAnnette M. MolinaroMichael D. Prados Clinical Trial Report 23 February 2017 Pages: 603 - 610
Phase I study of pazopanib plus TH-302 in advanced solid tumors Richard F. RiedelKellen L. MeadowsHerbert I. Hurwitz Clinical Trial Report 25 February 2017 Pages: 611 - 619
Impact of Laparotomy and Intraperitoneal Hyperthermic Instillation (LIHI) on the oxaliplatin pharmacokinetics after intravenous administration in Wistar rats María Isabel Mas-FusterAmelia Ramon-LopezRicardo Nalda-Molina Short Communication 06 February 2017 Pages: 621 - 627
Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia Yoshitaka NishikawaTaro FunakoshiManabu Muto Short Communication 15 February 2017 Pages: 629 - 633
Reply to: comment on “Meta-analysis of GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer” Xiangzhen Kong Letter to the Editor 22 February 2017 Pages: 635 - 635
